Podcasts

Dr Shitara Talks Trastuzumab Deruxtecan for Treatment in HER2-Positive Gastric Cancer

Kohei Shitara, MD, National Cancer Center Hospital East, Kashiwa, Japan, discusses trastuzumab deruxtecan for the treatment of patients with HER2-positive gastric cancer, an approval based on results following the DESTINY-Gastric01 study.

Stay in the know.
OncNet Newsletter